Log In
BCIQ
Print this Print this
 

Ridascreen Novovirus ELISA

  Manage Alerts
Collapse Summary General Information
Company R-Biopharm AG
DescriptionStool-based ELISA anti-NoV mAb mixture
Molecular Target
Mechanism of ActionDiagnostic
Therapeutic ModalityDiagnostics
Latest Stage of DevelopmentMarketed
Standard IndicationInfectious, Diagnostic
Indication DetailsPreliminary detection of norovirus infection in multiple patients with simultaneously-contracted gastroenteritis
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today